Literature DB >> 8159944

Maxillary dental arch and occlusion in patients with repaired clefts of the secondary palate. Influence of push back palatal surgery.

H Friede1, E C Persson, J Lilja, A Elander, A Lohmander-Agerskov, E Söderpalm.   

Abstract

Maxillary morphology and dental occlusion were studied from infancy to age 10 years in 32 patients born with isolated cleft palate. Wardill-Kilner push back repair of the palate had been done at a mean age of 7.5 months. Measurements obtained from casts of the jaws showed that the average maxillary dimensions before as well as after operation were less than those reported for children without clefts. The mean reduction was similar whether the cleft reached into the hard palate or affected the soft palate only. Preoperative anterior maxillary arch width in particular, and also distance from scar line to selected teeth seemed to influence postoperative development of the maxillary dental arch in individual patients.

Entities:  

Mesh:

Year:  1993        PMID: 8159944

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  3 in total

1.  Correlations between initial cleft size and dental anomalies in unilateral cleft lip and palate patients after alveolar bone grafting.

Authors:  Fatima Jabbari; Erika Reiser; Andreas Thor; Malin Hakelius; Daniel Nowinski
Journal:  Ups J Med Sci       Date:  2016-02-29       Impact factor: 2.384

2.  Timing Of Primary Surgery for cleft palate (TOPS): protocol for a randomised trial of palate surgery at 6 months versus 12 months of age.

Authors:  William Shaw; Gunvor Semb; Anette Lohmander; Christina Persson; Elisabeth Willadsen; Jill Clayton-Smith; Inge Kiemle Trindade; Kevin J Munro; Carrol Gamble; Nicola Harman; Elizabeth J Conroy; Dieter Weichart; Paula Williamson
Journal:  BMJ Open       Date:  2019-07-11       Impact factor: 2.692

3.  A randomised controlled trial comparing palate surgery at 6 months versus 12 months of age (the TOPS trial): a statistical analysis plan.

Authors:  Elizabeth J Conroy; Rachael Cooper; William Shaw; Christina Persson; Elisabeth Willadsen; Kevin J Munro; Paula R Williamson; Gunvor Semb; Tanya Walsh; Carrol Gamble
Journal:  Trials       Date:  2021-01-04       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.